glp-1 supply manufacturing news today Scaling for the Revolution GLP-1 shortage: Can biotechs keep

Millones de personas comenzaron a usar medicamentos como Ozempic y Wegovy en todo el mundo, generando ganancias millonarias para las empresas y transformando el tratamiento de la diabetes y obesidad

Moreover, OW semaglutide 2.4 mg was associated with a consistent benefit in HF composite endpoint, comprising death from CV causes or hospitalization or an urgent medical visit for HF (HR 0.82, 95% CI, 0.710.96), and death from any cause (HR 0.81, 95% CI, 0.710.93) 84

doi: 10.1136/bmj.i581 28

As a dietary supplement, take 1 capsule daily or as directed by a healthcare professional

That gap is real and worth knowing about